Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dosing on oxygenation in obese patients
NCT06355960Not yet recruiting
- Sponsor
- Cairo University
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in obesity (3 arms), sponsored by Cairo University. Primary endpoint: Oxygenation up to 6 hours. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06355960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355960.